Last updated: February 11, 2025
Sponsor: Clinique Saint François, Nice, France
Overall Status: Active - Recruiting
Phase
N/A
Condition
Osteoarthritis
Treatment
KeriFuse implant implantation
Clinical Study ID
NCT06151834
2023-A02072-43
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Eligible patients with osteoarthritis of finger for an interphalangeal arthrodesiswith KeriFuse implant
Exclusion
Exclusion Criteria:
Pregnant or breastfeeding patient
Patient with an intellectual disability and who therefore cannot follow thesurgeon's instructions
Patients with contraindications to surgery
Patients with acute or chronic, local or systemic infections
Patients with sensitivities or allergies to device components (Nickel, Titanium)
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: KeriFuse implant implantation
Phase:
Study Start date:
December 01, 2023
Estimated Completion Date:
September 01, 2026
Study Description
Connect with a study center
Clinique Saint François
Nice, 06000
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.